The US Food and Drug Administration (FDA) approved sarilumab (Kevzara) today for the treatment of polymyalgia rheumatica (PMR) in adults who have had an inadequate response to corticosteroids or could ...

Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...

DEAR DR. ROACH: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...

Background More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be ...

Polymyalgia rheumatica (PMR) is a systemic inflammatory disorder that predominantly affects individuals over the age of 50. It is characterised by pain and stiffness in the shoulder and hip girdles, ...

Credit: Shutterstock. Patients in the sarilumab vs placebo group achieved sustained remission of polymyalgia rheumatica at higher rates. Sarilumab demonstrates significant efficacy and is safe in the ...

DEAR DR. ROACH: I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which ...

DEAR DOCTORS: I am a 77-year-old man who used to exercise regularly. I was diagnosed with polymyalgia rheumatica a couple of years ago. Sometimes I feel like it is going to disappear, and other times ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...